What's new

[Cyprus Times] Coronavirus also affects the heart. The tactic that protects it

kardiaki-prosboli-emfragma.jpg

COVID-19 has been observed to be associated with a wide range of cardiac complications How vaccination can prevent serious cardiovascular disease

The association between the presence of risk factors or preexisting cardiovascular disease with increased risk of complications and mortality in patients with COVID-19 is unfortunately already established in the first months of the pandemic. Moreover, most viral lower respiratory tract infections cause more severe complications in patients with cardiovascular disease and exacerbate the underlying disease entity.

In the case of COVID-19 infection in particular, a wide range of cardiac complications have been observed, ranging from asymptomatic elevation of specific myocardial enzymes such as troponin to acute myocardial infarction and the worsening or development of new heart failure, the development of arrhythmias such as atrial fibrillation, and the development of thrombotic complications such as pulmonary embolism.

Available scientific data confirm the increased incidence of cardiovascular complications during illness, hospitalization and early within the first month after the onset of COVID-19 infection, and recent data highlight long-term cardiovascular complications within the first year of infection.

Vaccination against SARS-CoV-2 significantly reduces the risk of hospitalization, intubation and other serious immediate complications of COVID-19 infection, but until recently no data were available on the effect of vaccines on long-term cardiovascular risk after COVID-19 infection. Recently, a study published in the prestigious Journal of American Medical Association highlighted important aspects of the long-term benefit of vaccination, not in preventing severe disease, but in protecting against cardiovascular disease after infection.

The physicians of the Therapeutic Clinic of the Medical School of the National and Kapodistrian University of Athens, Alexandros Briassoulis (Assistant Professor of Cardiology), Kimon Stamatelopoulos (Professor of Cardiology) and Thanos Dimopoulos (Dean of EKPA) summarize these data that confirm the significant epidemiological impact of vaccination against SARS-COV-2, not only in terms of respiratory complications, but also in other body systems.

The study analyzed data from a large database of patients followed up in the South Korean Health System who were diagnosed with COVID-19 infection. Patients who had received only one dose of vaccine, had been hospitalized for more than 30 days, or had a recent acute cardiac problem in the past three months were excluded. The researchers compared 62,727 unvaccinated patients with 168,310 fully vaccinated patients. The fully vaccinated were older, with more comorbidities, but developed severe COVID-19 infection less often than the unvaccinated. Fully vaccinated patients showed more than 50% reduction in the risk of acute myocardial infarction as well as stroke within three months after infection.

These results were observed even after statistically equalizing the various comorbidities as well as the severity of COVID-19 infection between vaccinated and unvaccinated patients. In conclusion, COVID-19 infection can cause frequent and increased severity of complications, especially in patients with cardiovascular disease, and administration of the vaccine has been shown to lead to improved outcomes among susceptible patients with a wide range of cardiovascular problems, both through protection from severe infection and from distant cardiovascular complications after infection.



Source: ygeiamou.gr


Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times

Source
 
Back
Top